Radnet Inc
RDNT
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.84B
Close$
$-20.92
134% downside
Current Fair Value
134% downsideOvervalued by 134% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.84 Billion |
|---|---|
| Enterprise Value | $6.33 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.25 |
| Beta | 1.36 |
| Outstanding Shares | 77,057,835 |
Return
| Return on Equity | -1.31% |
|---|---|
| Return on Assets | -0.37% |
| Return on Invested Capital | 3.12% |
Valuation & Multiples
| P/E Ratio | -348.84 |
|---|---|
| PEG | - |
| Price to Sales | 2.28 |
| Price to Book Ratio | 3.62 |
| Enterprise Value to Revenue | 2.95 |
| Enterprise Value to EBIT | 62.5 |
| Enterprise Value to Net Income | -447 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 1.8 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$557.93 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$0.22
Average shareholder expectationRevenue Estimate
$608.76 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 24.44% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.49%▼ 101.03% |
|---|---|
| Total Invested | $71.02M▼ 98.35% |
| Investors Holding | 57▼ 292.00% |
ESG Score
No data
About Radnet Inc
CEO: Howard Berger Relevant Senate Committees
Finance
Controls Medicare and Medicaid policy; legislative movements to expand Medicare to include dental benefits would represent a massive revenue catalyst for the lab industry.
Health, Education, Labor, and Pensions
Directly oversees the FDA, which regulates dental materials and the 3D printing technologies increasingly used in dental labs.